About pavmed inc - PAVM
PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.
PAVM At a Glance
PAVmed, Inc.
360 Madison Avenue
New York, New York 10017
| Phone | 1-917-813-1828 | Revenue | 71.00K | |
| Industry | Medical Specialties | Net Income | 401.00K | |
| Sector | Health Technology | Employees | 41 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
PAVM Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 62.552 |
| Price to Book Ratio | 0.662 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -1.348 |
| Enterprise Value to Sales | 412.144 |
| Total Debt to Enterprise Value | 0.456 |
PAVM Efficiency
| Revenue/Employee | 1,731.707 |
| Income Per Employee | 9,780.488 |
| Receivables Turnover | 4.733 |
| Total Asset Turnover | 0.002 |
PAVM Liquidity
| Current Ratio | 0.172 |
| Quick Ratio | 0.172 |
| Cash Ratio | 0.104 |
PAVM Profitability
| Gross Margin | -354.93 |
| Operating Margin | -30,712.676 |
| Pretax Margin | -3,477.465 |
| Net Margin | 564.789 |
| Return on Assets | 1.154 |
| Return on Equity | 2.548 |
| Return on Total Capital | 0.848 |
| Return on Invested Capital | 2.266 |
PAVM Capital Structure
| Total Debt to Total Equity | 39.297 |
| Total Debt to Total Capital | 28.211 |
| Total Debt to Total Assets | 34.391 |
| Long-Term Debt to Equity | 18.032 |
| Long-Term Debt to Total Capital | 3.54 |